Stents in the Superficial Femoral Artery: The Future Looks Bright

Two recent events have brought stents into the spotlight for the future of treatment of the superficial femoral artery (SFA), says Frank J. Criado, MD, FACS, FSVM, clinical editor of Vascular Disease Management, in the VDM blog. One is presentation of results of a retrospective review of 517 patients in which more than half treated for claudication or critical limb ischemia with stenting of the SFA had primary patency at 5 years.

The other is the recent FDA approval of the Zilver PTX stent (Cook Medical) for peripheral arterial disease in the SFA. In a trial of the PTX stent, key outcomes include that 8 out of 10 patients treated with the device had patent arteries at 12 months compared to only 3 out of 10 patients treated with angioplasty alone.

Read more from Dr. Criado at “Stents Tighten Their Grip on the SFA.”

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s